Your browser doesn't support javascript.
loading
Epithelioid hemangioendothelioma, an ultra-rare cancer: a consensus paper from the community of experts.
Stacchiotti, S; Miah, A B; Frezza, A M; Messiou, C; Morosi, C; Caraceni, A; Antonescu, C R; Bajpai, J; Baldini, E; Bauer, S; Biagini, R; Bielack, S; Blay, J Y; Bonvalot, S; Boukovinas, I; Bovee, J V M G; Boye, K; Brodowicz, T; Callegaro, D; De Alava, E; Deoras-Sutliff, M; Dufresne, A; Eriksson, M; Errani, C; Fedenko, A; Ferraresi, V; Ferrari, A; Fletcher, C D M; Garcia Del Muro, X; Gelderblom, H; Gladdy, R A; Gouin, F; Grignani, G; Gutkovich, J; Haas, R; Hindi, N; Hohenberger, P; Huang, P; Joensuu, H; Jones, R L; Jungels, C; Kasper, B; Kawai, A; Le Cesne, A; Le Grange, F; Leithner, A; Leonard, H; Lopez Pousa, A; Martin Broto, J; Merimsky, O.
Affiliation
  • Stacchiotti S; Adult Mesenchymal Tumor and Rare Cancer Unit, Cancer Medicine Department, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy. Electronic address: silvia.stacchiotti@istitutotumori.mi.it.
  • Miah AB; The Royal Marsden Hospital and The Institute of Cancer Research, London, UK.
  • Frezza AM; Adult Mesenchymal Tumor and Rare Cancer Unit, Cancer Medicine Department, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
  • Messiou C; Department of Radiology, The Royal Marsden Hospital and The Institute of Cancer Research, London, UK.
  • Morosi C; Radiology Department, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
  • Caraceni A; Palliative Care Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
  • Antonescu CR; Department of Pathology, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, USA.
  • Bajpai J; Medical Oncology Department, Tata Memorial Centre, Homi Bhabha National Institute, Mumbai, India.
  • Baldini E; Department of Radiation Oncology, Dana-Farber Cancer Center/Brigham and Women's Hospital, Boston, USA.
  • Bauer S; Department of Medical Oncology, West German Cancer Center, Sarcoma Center, University of Duisburg-Essen, University Hospital, Essen, Germany.
  • Biagini R; Orthopaedic Department, Regina Elena National Cancer Institute, Rome, Italy.
  • Bielack S; Klinikum Stuttgart - Olgahospital, Zentrum für Kinder-, Jugend- und Frauenmedizin, Stuttgart Cancer Center, Pädiatrische Onkologie, Hämatologie, Immunologie, Stuttgart, Germany.
  • Blay JY; Department of Medical Oncology, Centre Leon Berard, Université Claude Bernard Lyon, Unicancer, Lyon, France.
  • Bonvalot S; Department of Surgical Oncology, Institut Curie, Université Paris Sciences et Lettres, Paris, France.
  • Boukovinas I; Nordix, Athens, Greece.
  • Bovee JVMG; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
  • Boye K; Department of Oncology, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway.
  • Brodowicz T; Medical University Vienna & General Hospital Department of Internal Medicine 1/Oncology, Vienna, Austria.
  • Callegaro D; Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • De Alava E; Institute of Biomedicine of Sevilla (IBiS), Virgen del Rocio University Hospital/CSIC/University of Sevilla/CIBERONC, Seville, Spain; Department of Normal and Pathological Cytology and Histology, School of Medicine, University of Seville, Seville, Spain.
  • Deoras-Sutliff M; The EHE Foundation, Wisconsin, USA.
  • Dufresne A; Department of Medical Oncology, Centre Leon Berard, Université Claude Bernard Lyon, Unicancer, Lyon, France.
  • Eriksson M; Department of Oncology, Skane University Hospital and Lund University, Lund, Sweden.
  • Errani C; Orthopaedic Service, Musculoskeletal Oncology Department, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.
  • Fedenko A; Medical Oncology Division, P.A. Herzen Cancer Research Institute, Moscow, Russian Federation.
  • Ferraresi V; Sarcomas and Rare Tumors Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
  • Ferrari A; Paediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.
  • Fletcher CDM; Department of Pathology Brigham & Women's Hospital, Boston, USA.
  • Garcia Del Muro X; University of Barcelona and Genitourinary Cancer and Sarcoma Unit Institut Català d'Oncologia, Hospitalet, Barcelona, Spain.
  • Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.
  • Gladdy RA; University of Toronto and Lunenfeld-Tanenbaum Research Institute, Toronto, Canada.
  • Gouin F; Department of Surgery, Centre Leon Berard, Lyon, France.
  • Grignani G; Division of Medical Oncology, Candiolo Cancer Institute, FPO - IRCCS, Candiolo, Italy.
  • Gutkovich J; The EHE Foundation, Wisconsin, USA; NUY Langone Medical Center, New York, USA.
  • Haas R; Department of Radiotherapy, the Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Radiotherapy, the Leiden University Medical Center, Leiden, the Netherlands.
  • Hindi N; Group of Advanced Therapies and Biomarkers in Sarcoma, Institute of Biomedicine of Seville (IBIS, HUVR, CSIC, Universidad de Sevilla), Seville, Spain.
  • Hohenberger P; Division of Surgical Oncology & Thoracic Surgery, Mannheim University Medical Center, University of Heidelberg, Heidelberg, Germany.
  • Huang P; Division of Molecular Pathology, The Institute of Cancer Research, London, UK.
  • Joensuu H; Department of Oncology, Helsinki University Hospital & Helsinki University, Helsinki, Finland.
  • Jones RL; Department of Cancer, The Royal Marsden Hospital and The Institute of Cancer Research, London, UK.
  • Jungels C; Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.
  • Kasper B; University of Heidelberg, Mannheim University Medical Center, Sarcoma Unit, Mannheim, Germany.
  • Kawai A; Musculoskeletal Oncology and Rehabilitation Medicine, Rare Cancer Center National Cancer Center Hospital, Tokyo, Japan.
  • Le Cesne A; International Department, Gustave Roussy, Villejuif, France.
  • Le Grange F; UCLH - University College London Hospitals NHS Foundation Trust, London, UK.
  • Leithner A; Department of Orthopaedics and Trauma Medical University Graz, Graz, Austria.
  • Leonard H; Chair of Trustees of the EHE Rare Cancer Charity (UK), Charity number 1162472.
  • Lopez Pousa A; Medical Oncology Department, Hospital Universitario Santa Creu i Sant Pau, Barcelona, Spain.
  • Martin Broto J; Hospital Universitario Fundación Jimenez Diaz, Madrid, Spain.
  • Merimsky O; Unit of Soft Tissue and Bone Oncology, Division of Oncology, Tel-Aviv Medical Center affiliated with Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
ESMO Open ; 6(3): 100170, 2021 06.
Article in En | MEDLINE | ID: mdl-34090171
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sarcoma / Hemangioendothelioma, Epithelioid Type of study: Diagnostic_studies / Guideline Limits: Adult / Child / Humans Language: En Journal: ESMO Open Year: 2021 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Sarcoma / Hemangioendothelioma, Epithelioid Type of study: Diagnostic_studies / Guideline Limits: Adult / Child / Humans Language: En Journal: ESMO Open Year: 2021 Document type: Article